![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
Effects of serum uric acid on blood-pressure lowering treatment
1a Clinica Medica , University of Milano-Bicocca and IRCCS Multimedica , Sesto San Giovanni , Milan , Italy.
Current Medical Research and Opinion
|September 28, 2017
Insights
Hyperuricemia, high uric acid levels, may independently impact blood pressure control. Urate-lowering therapy could reduce cardiovascular risks associated with this condition.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Disorders
Background:
- Hyperuricemia is increasingly recognized for its potential role beyond gout.
- Elevated uric acid levels are associated with various metabolic and cardiovascular abnormalities.
- The precise relationship between hyperuricemia and hypertension requires further elucidation.
Purpose of the Study:
- To review the current scientific evidence linking hyperuricemia and hypertension.
- To assess whether hyperuricemia is an independent risk factor for blood pressure regulation.
- To explore the implications of hyperuricemia as a prognostic marker for cardiovascular risk.
Main Methods:
- Systematic literature review of observational studies and clinical trials.
- Analysis of data correlating serum uric acid levels with blood pressure measurements.
- Evaluation of studies investigating the effects of urate-lowering therapies on hypertension and cardiovascular outcomes.
Main Results:
- Evidence suggests a correlation between hyperuricemia and elevated blood pressure.
- Hyperuricemia may act as an independent risk factor in hypertension management.
- Urate-lowering interventions show potential in mitigating cardiovascular risks in hyperuricemic individuals.
Conclusions:
- Hyperuricemia is a significant factor to consider in the context of hypertension.
- Therapeutic lowering of uric acid levels may be beneficial for cardiovascular risk reduction.
- Further research is warranted to fully understand the prognostic value of hyperuricemia.
Abstract:
If hyperuricemia is an independent risk factor in blood-pressure control, urate-lowering therapy should be used to reduce cardiovascular risk. It may also act as a prognostic marker of other abnormalities. This review presents current evidence on the relationship between hyperuricemia and hypertension.
Related Concept Videos
01:16Antihypertensive Drugs: Action of Diuretics
2.5K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
01:30Urinary Tract Calculi III: Medical Management
291
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
291
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.8K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K
01:24Serum Studies: Renal Function Tests
478
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
478
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K